Filing Details
- Accession Number:
- 0001651844-19-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-01 15:13:27
- Reporting Period:
- 2019-06-28
- Accepted Time:
- 2019-07-01 15:13:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-28 | 1,110 | $1.48 | 3,461,660 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-29 | 3,155 | $1.52 | 3,464,815 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-29 | 920 | $150.00 | 3,465,735 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-29 | 1,000 | $1.49 | 3,466,735 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-29 | 3,015 | $1.48 | 3,469,750 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-29 | 800 | $1.48 | 3,470,550 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |